Abstract:Background: Epilepsy is the most common neurological manifestation in individuals with tuberous sclerosis complex (TSC). However, real-world evidence on diagnosis and treatment patterns is limited. Here, we present data from TuberOus Sclerosis registry to increase disease Awareness (TOSCA) on changes in patterns of epilepsy diagnosis, treatments, and outcomes over time, and detailed epilepsy characteristics from the epilepsy substudy. Methods: TuberOus Sclerosis registry to increase disease Awareness (TOSCA) was a multicentre, international disease registry, consisting of a main study that collected data on overall diagnostic characteristics and associated clinical features, and six substudies focusing on specific TSC manifestations. The epilepsy substudy investigated detailed epilepsy characteristics and their correlation to genotype and intelligence quotient (IQ). Results: Epilepsy was reported in 85% of participants, more commonly in younger individuals (67.8% in 1970s to 91.8% in last decade), while rate of treatments was similar across ages (>93% for both infantile spasms and focal seizures, except prior to 1960). Vigabatrin (VGB) was the most commonly used antiepileptic drugs (AEDs). Individuals with infantile spasms showed a higher treatment response over time with lower usage of steroids. Individuals with focal seizures reported similar rates of drug resistance (32.5–43.3%). Use of vagus nerve stimulation (VNS), ketogenic diet, and surgery remained low. Discussion: The epilepsy substudy included 162 individuals from nine countries. At epilepsy onset, most individuals with infantile spasms (73.2%) and focal seizures (74.5%) received monotherapies. Vigabatrin was first-line treatment in 45% of individuals with infantile spasms. Changes in initial AEDs were commonly reported due to inadequate efficacy. TSC1 mutations were associated with less severe epilepsy phenotypes and more individuals with normal IQ. In individuals with TSC diagnosis before seizure onset, electroencephalogram (EEG) was performed prior to seizures in only 12.5 and 25% of subsequent infantile spasms and focal seizures, respectively. Conclusions: Our study confirms the high prevalence of epilepsy in TSC individuals and less severe phenotypes with TSC1 mutations. Vigabatrin improved the outcome of infantile spasms and should be used as first-line treatment. There is, however, still a need for improving therapies in focal seizures. Electroencephalogram follow-up prior to seizure-onset should be promoted for all infants with TSC in order to facilitate preventive or early treatment.

Independent Temporal Lobe Epilepsy in Patients with Tuberous Sclerosis Complex

Long-term outcomes of epilepsy surgery in tuberous sclerosis complex

Epilepsy Surgery for Low-Grade Epilepsy-Associated Neuroepithelial Tumor of Temporal Lobe: a Single-Institution Experience of 61 Patients

Multimodal Approach in the Surgical Treatment of Refractory Epilepsy Associated with Tuberous Sclerosis Complex: A Series of Three Cases

Resective epilepsy surgery in tuberous sclerosis complex: a nationwide multicentre retrospective study from China

EEG features of patients with epileptic seizure secondary to tuberous sclerosis complex

Treatment of Foci Resection and Bipolar Electro- Coagulation on Functional Cortex in Tuberous Sclerosis Complex Involving Eloquent Cortex

Clinical and Pathological Characteristics of Nine Cases of Tuberous Sclerosis in Refractory Epilepsy

Predictors and Long-term Outcome of Resective Epilepsy Surgery in Patients with Tuberous Sclerosis Complex: A Single-centre Retrospective Cohort Study.

Temporal lobe epilepsy: neuropathological and clinical correlations in 243 surgically treated patients

Optimization and high-density array of stereoelectroencephalography-guided radiofrequency thermocoagulation for the treatment of pediatric tuberous sclerosis complex with epilepsy

Cortical Excitability In Temporal Lobe Epilepsy With Bilateral Tonic-Clonic Seizures

476 Middle Cranial Fossa Encephaloceles With Temporal Lobe Epilepsy: An Underdiagnosed Entity

The clinical features of the patients with seizure secondary to tuberous sclerosis complex

Historical Patterns of Diagnosis, Treatments, and Outcome of Epilepsy Associated with Tuberous Sclerosis Complex: Results from TOSCA Registry

Tuberous sclerosis complex presenting as convulsive status epilepticus followed by hypoxic cerebropathy: A case report

Effect of Epileptic Seizure on Intelligence of Patients with Tuberous Sclerosis Complex

Progressive Cystic Lesion in a Middle-Aged Patient with Tuberous Sclerosis Complex: A Case Report.

Pathways to epilepsy surgery in children with tuberous sclerosis complex-associated epilepsy

Study on concordance of ictal and interictal epileptiform activity in patients with tuberous sclerosis complex

A study of medial and lateral temporal lobe epilepsy based on stereoelectroencephalography